RecruitingNCT05169333
The Oxford Risk Factors And Non-Invasive Imaging Study
Sponsor
University of Oxford
Enrollment
250,000 participants
Start Date
Feb 23, 2016
Study Type
OBSERVATIONAL
Conditions
Summary
ORFAN is a prospective, multi-centre, multi-ethnic cohort observational study collecting CT scans, biological material and outcomes data, to develop and validate novel biomarkers of cardiometabolic and other disease risk.
Eligibility
Min Age: 18 YearsMax Age: 99 Years
Inclusion Criteria3
- Participant is willing and able to give informed consent for participation in the study.
- Male or Female, aged 18 -99 years.
- Male or Female, aged 18 -99 years.
Exclusion Criteria4
- Unable or unwilling to consent
- Active cancer
- Participation in Study Arms 1, 2 or 3
- Existing opt-out from use of data for research purposes
Interested in this trial?
Get notified about updates and connect with the research team.
Locations(37)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT05169333
Related Trials
Diabetes and Heart Disease Risk in Blacks
NCT000018531 location
Moderate-Intensity Statin Plus Ezetimibe in CKD and ASCVD
NCT075241011 location
Biomedical Research Informatics Centre for Cardiovascular Sciences (The BRICCS Study)
NCT043889431 location
EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease
NCT070644731155 locations
Cardiovascular Disease Progression in Survivors of Community Acquired Pneumonia and Lung Infection by Covid-19.
NCT0660199818 locations